0
Politics
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
April 30, 2026
Scroll
Posted 2 hours ago by
Lilly hiked its full-year sales outlook by 2 billion, and also raised its adjusted profit guidance.
CNBC
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.